Cutler Group LP Sutro Biopharma, Inc. Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$3.41 - $8.95 $1,909 - $5,012	-560 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$7.78 - $15.31 $15,560 - $30,620	-2,000 Reduced 78.13%	560 $4,000
Q2 2021 Jul 19, 2021	SELL	$18.03 - $23.82 $18,030 - $23,820	-1,000 Reduced 28.09%	2,560 $47,000
Q1 2021 Apr 26, 2021	BUY	$20.29 - $27.54 $72,232 - $98,042	3,560 New	3,560 $81,000

132

63.1M

205K

28.1K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $93.4M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.